Posted by Michael Wonder on 08 Feb 2021
Puzzle Medical Devices receives U.S. FDA breakthrough device designation for its revolutionary minimally invasive transcatheter heart pump
8 February 2021 - Puzzle Medical Devices announced today that the U.S. FDA has granted the company a breakthrough revice designation for its revolutionary transcatheter pump to address heart failure.
Puzzle Medical is developing a proprietary transcatheter heart pump associated with minimal trauma to the blood components, allowing for safe and efficient heart support without open-heart surgery.
